This Biotech Stock Soared: Why One Fund Sold $3 Million
A biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
Explore which altcoins have strong teams and performance, highlighting projects with solid development and momentum. Learn how team credibility aligns with price trends and long-term potential.
28,575 articlesA biotech rally can be thrilling, but a large fund selling into the run-up often signals caution. This article unpack...
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
Biotech investing offers life-changing upside, but it also comes with steep risks. This guide breaks down whether cou...
Tesla pushed out a solid delivery quarter, but the stock didn’t follow. This article breaks down what the numbers mea...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
As Warren Buffett steps back, Greg Abel’s potential move to buy a stock Buffett loves has investors buzzing. This art...
Oil climbs and stock futures rise as renewed U.S.-Iran clashes raise supply disruption fears in the Persian Gulf.
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
Even as global drinking declines, Anheuser-Busch InBev shows resilience through a diversified brand mix, cost discipl...
When rates trend downward, cash-flow investors face a tougher math as prices rise and competition heats up. This guid...
Greg Abel’s early moves at Berkshire Hathaway signal a new investment ethos. This analysis breaks down the rationale,...
When wealth and fame meet legal drama, discovery battles can reshape costs and outcomes. This article breaks down the...